Pham Quang X 4
4 · Cadrenal Therapeutics, Inc. · Filed Oct 1, 2025
Insider Transaction Report
Form 4
Pham Quang X
DirectorCEO and Chairman10% Owner
Transactions
- Sale
Common Stock
2025-10-01$14.01/sh−881$12,343→ 202,633 total - Sale
Common Stock
2025-09-29$14.01/sh−419$5,870→ 203,514 total
Holdings
- 200,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $13.99 through $14.02, inclusive, having a weighted average price as shown in column 4 of $14.01. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $13.99 through $14.05, inclusive, having a weighted average price as shown in column 4 of $14.01. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and disposition power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.